VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Glatopa

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Glatopa is an FDA-approved generic substitute for COPAXONE® (glatiramer acetate injection).

  • Biotech & therapeutics
Status
Operatingas of 2026-09-17
Open relationship map
Claim, correct or request removal

Record updated 17 September 2026

About

Glatopa is a generic version of COPAXONE® (glatiramer acetate injection) to treat relapsing-forms of multiple sclerosis1,2

Products

Other
Glatopa
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy